Gynecologic Surgeon Meet Robert W. Holloway, MD
Dr. Holloway has earned the respect of his colleagues as a consultant gynecologic oncologist and gynecologic surgeon. In 2007 Dr. Holloway was named "Surgeon of the Year" by the Orange County Medical Society and each year since 2005 he has been voted “Best Doctor” in Orlando by his peers. Dr. Holloway is recognized internationally for his robotic surgery skills.
Dr. Holloway routinely travels as a course director and speaker at robotic symposia including university programs in South America, Europe, and Japan. American and International surgeons frequently attend advanced training courses at AdventHealth under his direction, and post-graduate Fellows in the 3-year gynecologic oncology training program at AdventHealth graduate with expert surgical skills in the management of gynecologic cancer and complex benign pathology.
Recognized Internationally for Robotic Surgery
As a recognized expert in gynecologic oncology, Dr. Holloway is a featured presenter at GOG, ASCO, and SGO national conferences. In pursuit of medical excellence, Dr. Holloway is the principal investigator for several clinical trials and research projects. In collaboration with AdventHealth PhD scientists, he actively participates in the basic research of novel therapies for ovarian cancer. Dr. Holloway publishes scientific articles regularly and is an associate editor for the Journal of Robotic Surgery.
Dr. Holloway earned his medical degree from Vanderbilt University and completed a gynecology and oncology fellowship at Georgetown University Hospital. Even as co-medical director of AdventHealth Gynecologic Oncology, a founding member of AdventHealth's Global Robotic Institute, clinical professor at the University of Central Florida College of Medicine, Dr. Holloway insists his skills all come down to working with his hands, a trait he picked up while on the farm.
Robotic-Assisted Gynecologic Oncology
Find out why our Gynecologic Oncology Center treats more patients than any similar program in the Southeast.
Achievements, Research, and Published Work
- Achievements
-
Education and Fellowships
Fellowship: Georgetown University Hospital, Washington D.C.
Residency: University of Alabama at Birmingham, Obstetrics and Gynecology
Medical School: Vanderbilt University, Nashville, TN
Undergraduate: University of Illinois, Champaign-Urbana
Accreditation
American Board of Obstetrics and Gynecology
American Board of Obstetrics and Gynecology, Gynecologic Oncology Certification
Fellowship American College Obstetrics and Gynecology
Fellowship American College Surgeons
Areas of Specialty
Radical pelvic surgery and reconstruction
Robotic assisted hysterectomy and lymphadenectomy for gynecologic cancers
Robotic assisted surgery for advanced, complex benign disease (endometriosis, leiomyomata, adnexal masses, and complex hyperplasia)
Investigational therapeutics for advanced ovarian cancer
Professional Memberships
American College of Obstetrics and Gynecology
Society of Gynecologic Oncologists
American College of Surgeons
American Society of Clinical Oncology
Charles E. Flowers Medical Society
Florida Association of Clinical Oncology
Florida Society of Gynecologic Oncologists
- Current Research Projects
-
Cellular Therapy in Combination with Cytokines as Treatment of Ovarian Cancer 2009-2012
Drs. Ingersoll (PI), Edwards, Finkler, Holloway, Ahmad
Funded by: Bankhead-Coley Cancer Research Program (Florida Department of Health) for $374, 049Relevance of Stat3 Pathway in Ovarian Cancer: Therapeutic Implications. 2009-2010
Drs. Holloway (PI-FH), Turkson (PI-UCF), Yue (UCF), Ingersoll, Ahmad
Funded by: Gala Endowed Foundation for Oncologic Research for $45,000Pre-Clinical Models to Investigate Cellular Therapy for Ovarian Cancer. 2009-2010
Drs. Ahmad (PI), Ingersoll, Holloway, Edwards
Funded by: Gala Endowed Foundation for Oncologic Research for $20,000Investigation of MicroRNA Expression Profile and its Correlation with Ovarian Cancer Response to Cellular Therapy. 2010-2011
Drs. Ingersoll (PI), Ahmad, Holloway, Finkler, Stoltzfus
Funded by: Teresa Rosebrough Research Fund (Ovarian Cancer Alliance of Florida) for $15,000Analysis of the EGFR-Erkmapkand EGFR-Stat3 Pathway in Recurrent and Resistant Ovarian Cancer. 2010-2011
Drs. Holloway (PI-FH), Turkson (PI-UCF), Yue (UCF), Sengupta (UCF), Ingersoll, Ahmad
Funded by: Gala Endowed Foundation for Oncologic Research for $45,000MicroRNA Expression Profile of Ovarian Cancer: Correlation to Cellular Therapy Responser. 2010-2011
Drs. Holloway (PI-FH), Turkson (PI-UCF), Yue (UCF), Sengupta (UCF), Ingersoll, Ahmad
Funded by: Gala Endowed Foundation for Oncologic Research for $20,000 - Published Work
-
Dr. Holloway has authored and coauthored more than 74 abstracts and publications to date, including:
- Holloway RW, Ahmad S, DeNardis SA, Peterson LB, Sultana N, Bigsby IV GE, Pikaart DP, Finkler NJ. Robotic-assisted laparoscopic hysterectomy with lymphadenectomy for endometrial cancer: Analysis of surgical performance. Gynecol. Oncol., 2009; 115:447-452
- Holloway RW, Patel SD, Ahmad S. Robotic surgery in gynecology. Scand. J. Surg. 2009; 98: 96-109.
- Mendivil A, Holloway RW, Boggess JF. Emergence of robotic assisted surgery in gynecologic oncology. Gynecol. Oncol. 2009; 114 (2 Suppl.): S24-31.
- Ingersoll SB, Patel S, Caballero L, Ahmad S, Edwards D, Holloway RW, Edwards JR. Synergistic cytotoxicity of interferon-a2b and interleukin-2 in combination with PBMC against ovarian cancer: Development of an experimental model for cellular therapy. Gynecol. Oncol. 2009; 112: 192-198.
- Holloway RW. Tolerability, Efficacy, and Safety of Pegylated Liposomal Doxorubicin in Combination With Carboplatin Versus Gemcitabine/Carboplatin for the Treatment of Platinum Sensitive Recurrent Ovarian Cancer: A Systematic Review. The Oncologists. 2010